Dr. Benjamin S. Citrin, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Vanderbilt University School of Medicine (1989)
- Years since graduation
- 37
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 433
Licensed in Alabama since 1995, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1989Medical school: Vanderbilt University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
AL license 18816 (first issued 1995; active) -
Cardiovascular Disease Physician
AL license 18816 (first issued 1995; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mobile Infirmary Medical Center Mobile, AL
- USA Health HCA Providence Hospital, LLC Mobile, AL
- Northwest Medical Center-Springdale Springdale, AR
Medical groups
- Northwest Benton County Physician Services LLC (36 clinicians)
- Citrin Cardiology PC (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 433
- Services billed
- 5,982
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,250 | 452 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 1,034 | 22 |
| Insertion of needle into vein for collection of blood sample | 693 | 344 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 551 | 415 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 535 | 66 |
| Blood test, lipids (cholesterol and triglycerides) | 322 | 308 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 244 | 122 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 210 | 207 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 180 | 100 |
| Blood count, hemoglobin | 157 | 117 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Mobile, AL | 1,764 |
| Ezetimibe Other prescribers in Mobile, AL | 1,429 |
| Carvedilol Other prescribers in Mobile, AL | 1,335 |
| Amlodipine Besylate Other prescribers in Mobile, AL | 1,168 |
| Eliquis (apixaban) Other prescribers in Mobile, AL | 960 |
| Nifedipine Er (nifedipine) Other prescribers in Mobile, AL | 863 |
| Losartan-Hydrochlorothiazide (losartan/hydrochlorothiazide) Other prescribers in Mobile, AL | 826 |
| Potassium Chloride Other prescribers in Mobile, AL | 648 |
| Torsemide Other prescribers in Mobile, AL | 604 |
| Rosuvastatin Calcium Other prescribers in Mobile, AL | 539 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 72 payments worth $1,201 in total to this clinician.
| Scpharmaceuticals Inc. | $430 |
|---|---|
| Novo Nordisk Inc | $162 |
| AstraZeneca Pharmaceuticals LP | $145 |
| Merck Sharp & Dohme LLC | $62.13 |
| Esperion Therapeutics, Inc. | $60.22 |
| Novartis Pharmaceuticals Corporation | $49.22 |
| Medtronic, Inc. | $48.83 |
| Bayer HealthCare Pharmaceuticals Inc. | $44.20 |
| Food and Beverage | $1,201 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.